Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Large Increase in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 3,100 shares, a growth of 6.9% from the January 15th total of 2,900 shares. Based on an average daily trading volume, of 11,900 shares, the short-interest ratio is presently 0.3 days.

Institutional Trading of Invesco Nasdaq Biotechnology ETF

Hedge funds and other institutional investors have recently made changes to their positions in the business. Strategic Financial Concepts LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at $1,699,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after buying an additional 48,137 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter worth about $888,000. Tower Research Capital LLC TRC grew its holdings in shares of Invesco Nasdaq Biotechnology ETF by 148.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock valued at $604,000 after acquiring an additional 16,768 shares in the last quarter. Finally, Advisory Services Network LLC increased its position in shares of Invesco Nasdaq Biotechnology ETF by 5.8% in the fourth quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock valued at $1,154,000 after acquiring an additional 2,922 shares during the last quarter.

Invesco Nasdaq Biotechnology ETF Stock Up 0.4 %

Shares of NASDAQ:IBBQ traded up $0.09 during mid-day trading on Tuesday, reaching $22.67. 9,795 shares of the stock were exchanged, compared to its average volume of 12,522. The company has a market cap of $40.13 million, a P/E ratio of 17.39 and a beta of 0.61. The stock’s 50 day simple moving average is $22.08 and its 200-day simple moving average is $23.09. Invesco Nasdaq Biotechnology ETF has a one year low of $20.14 and a one year high of $24.84.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were paid a dividend of $0.0619 per share. The ex-dividend date of this dividend was Monday, December 23rd.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.